TY - JOUR
T1 - Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis
AU - Bustos, Luis
AU - Echiburú-Chau, Carlos
AU - Castro-Alvarez, Alejandro
AU - Bradshaw, Ben
AU - Simirgiotis, Mario J.
AU - Mellado, Marco
AU - Parra, Claudio
AU - Cuellar, Mauricio
N1 - Funding Information:
This research was funded by ANID, grant number R15F10011. C.P. acknowledges Fondecyt 11190698. M.J.S. acknowledges Fondecyt 1220075. M.C. acknowledges Programa Formación de Capital Humano Avanzado 21130456. M.M. acknowledges Postdoctoral Fondecyt 3180408.Acknowledgments: The authors wish to express their gratitude to the Rectoría of Universidad de Tarapacá for their financial and administrative support.
Funding Information:
Funding: This research was funded by ANID, grant number R15F10011. C.P. acknowledges Fondecyt 11190698. M.J.S. acknowledges Fondecyt 1220075. M.C. acknowledges Programa Formación de Capital Humano Avanzado 21130456. M.M. acknowledges Postdoctoral Fondecyt 3180408.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - This study aimed to determine the in vitro cytotoxicity and understand possible cytotoxic mechanisms via an in silico study of eleven chalcones synthesized from two acetophenones. Five were synthesized from a prenylacetophenone isolated from a plant that grows in the Andean region of the Atacama Desert. The cytotoxic activity of all the synthesized chalcones was tested against breast cancer cell lines using an MTT cell proliferation assay. The results suggest that the prenyl group in the A-ring of the methoxy and hydroxyl substituents of the B-ring appear to be crucial for the cytotoxicity of these compounds. The chalcones 12 and 13 showed significant inhibitory effects against growth in MCF-7 cells (IC50 4.19 ± 1.04 µM and IC50 3.30 ± 0.92 µM), ZR-75-1 cells (IC50 9.40 ± 1.74 µM and IC50 8.75 ± 2.01µM), and MDA-MB-231 cells (IC50 6.12 ± 0.84 µM and IC50 18.10 ± 1.65 µM). Moreover, these chalcones showed differential activity between MCF-10F (IC50 95.76 ± 1.52 µM and IC50 95.11 ± 1.97 µM, respectively) and the tumor lines. The in vitro results agree with molecular coupling results, whose affinity energies and binding mode agree with the most active compounds. Thus, compounds 12 and 13 can be considered for further studies and are candidates for developing new antitumor agents. In conclusion, these observations give rise to a new hypothesis for designing chalcones with potential cytotoxicity with high potential for the pharmaceutical industry.
AB - This study aimed to determine the in vitro cytotoxicity and understand possible cytotoxic mechanisms via an in silico study of eleven chalcones synthesized from two acetophenones. Five were synthesized from a prenylacetophenone isolated from a plant that grows in the Andean region of the Atacama Desert. The cytotoxic activity of all the synthesized chalcones was tested against breast cancer cell lines using an MTT cell proliferation assay. The results suggest that the prenyl group in the A-ring of the methoxy and hydroxyl substituents of the B-ring appear to be crucial for the cytotoxicity of these compounds. The chalcones 12 and 13 showed significant inhibitory effects against growth in MCF-7 cells (IC50 4.19 ± 1.04 µM and IC50 3.30 ± 0.92 µM), ZR-75-1 cells (IC50 9.40 ± 1.74 µM and IC50 8.75 ± 2.01µM), and MDA-MB-231 cells (IC50 6.12 ± 0.84 µM and IC50 18.10 ± 1.65 µM). Moreover, these chalcones showed differential activity between MCF-10F (IC50 95.76 ± 1.52 µM and IC50 95.11 ± 1.97 µM, respectively) and the tumor lines. The in vitro results agree with molecular coupling results, whose affinity energies and binding mode agree with the most active compounds. Thus, compounds 12 and 13 can be considered for further studies and are candidates for developing new antitumor agents. In conclusion, these observations give rise to a new hypothesis for designing chalcones with potential cytotoxicity with high potential for the pharmaceutical industry.
KW - antioxidant
KW - bioactive compounds
KW - breast cancer
KW - cytotoxic
KW - molecular docking
KW - Senecio nutans
KW - synthesis
UR - http://www.scopus.com/inward/record.url?scp=85134539153&partnerID=8YFLogxK
U2 - 10.3390/molecules27144387
DO - 10.3390/molecules27144387
M3 - Article
AN - SCOPUS:85134539153
SN - 1420-3049
VL - 27
JO - Molecules
JF - Molecules
IS - 14
M1 - 4387
ER -